PDG14 COST-UTILITY OF DALBAVANCIN VERSUS STANDARD OF CARE (SOC) IN PATIENTS WITH ABSSSI IN ITALY. - Rotundo, M.; Bini, C.; Marcellusi, A.; Mennini, F.S. (Value in Health, 2019)